Advertisement

July 28, 2020

Cerus Endovascular Receives CE Mark Approval for the CerusEndo MC 021 Microcatheter

July 28, 2020—Cerus Endovascular Ltd. announced that it has received CE Mark approval for its CerusEndo MC 021 microcatheter, which is designed to access tortuous neurovasculature and deliver therapeutic devices to intended targets. The company expects to begin commercial sales across the European Union during Q4 2020.

The CerusEndo MC 021 microcatheter will be available in multiple distal flexible profiles and is designed to offer superior proximal support for enhanced deliverability and responsiveness in physicians’ hands. In February 2020, the company announced FDA approval for the device.

Advertisement


July 28, 2020

National Blood Clot Alliance Receives CDC Grant to Support COVID-19 Research and Public Awareness Campaign

July 27, 2020

Results From REACH PVI Study of CSI's Transradial Orbital Atherectomy Systems in Lower Extremities Presented